Development of Macrocyclic Neurotensin Receptor Type 2 (NTS2) Opioid‐Free Analgesics
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Development of Macrocyclic Neurotensin Receptor Type 2 (NTS2) Opioid‐Free Analgesics ; day:14 ; month:10 ; year:2024 ; extent:25
Angewandte Chemie / International edition. International edition ; (14.10.2024) (gesamt 25)
- Urheber
-
Desgagné, Michael
Chartier, Magali
Lagard, Camille
Ferková, Sára
Choquette, Mathieu
Longpré, Jean‐Michel
Côté, Jérôme
Boudreault, Pierre‐Luc
Sarret, Philippe
- DOI
-
10.1002/anie.202405941
- URN
-
urn:nbn:de:101:1-2410151415040.181639401512
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Desgagné, Michael
- Chartier, Magali
- Lagard, Camille
- Ferková, Sára
- Choquette, Mathieu
- Longpré, Jean‐Michel
- Côté, Jérôme
- Boudreault, Pierre‐Luc
- Sarret, Philippe
Ähnliche Objekte (12)
Development of Macrocyclic Neurotensin Receptor Type 2 (NTS2) Opioid‐Free Analgesics
Non-opioid (OTC) analgesics : risks/benefits in perspective
Nociceptin/orphanin FQ opioid peptide receptor-related ligands as potential analgesics in the endometriosis-associated pain
Oxycodone versus other opioid analgesics after laparoscopic surgery: a meta-analysis
Endomorphins: Promising Endogenous Opioid Peptides for the Development of Novel Analgesics
Differential interaction patterns of opioid analgesics with µ opioid receptors correlate with ligand-specific voltage sensitivity
Attenuated G protein signaling and minimal receptor phosphorylation as a biochemical signature of low side-effect opioid analgesics
Label-free integrative pharmacology on-target of opioid ligands at the opioid receptor family
Erratum to: Pain Management in Patients with Cancer: Focus on Opioid Analgesics
Enhancement of the intestinal epithelial permeability of peripherally acting opioid analgesics by chitosan
Correction to: Oxycodone versus other opioid analgesics after laparoscopic surgery: a meta-analysis
Enhancement of the intestinal epithelial permeability of peripherally acting opioid analgesics by chitosan
Development of Macrocyclic Neurotensin Receptor Type 2 (NTS2) Opioid‐Free Analgesics
Non-opioid (OTC) analgesics : risks/benefits in perspective
Nociceptin/orphanin FQ opioid peptide receptor-related ligands as potential analgesics in the endometriosis-associated pain
Oxycodone versus other opioid analgesics after laparoscopic surgery: a meta-analysis
Endomorphins: Promising Endogenous Opioid Peptides for the Development of Novel Analgesics
Differential interaction patterns of opioid analgesics with µ opioid receptors correlate with ligand-specific voltage sensitivity
Attenuated G protein signaling and minimal receptor phosphorylation as a biochemical signature of low side-effect opioid analgesics
Label-free integrative pharmacology on-target of opioid ligands at the opioid receptor family
Erratum to: Pain Management in Patients with Cancer: Focus on Opioid Analgesics
Enhancement of the intestinal epithelial permeability of peripherally acting opioid analgesics by chitosan
Correction to: Oxycodone versus other opioid analgesics after laparoscopic surgery: a meta-analysis
Enhancement of the intestinal epithelial permeability of peripherally acting opioid analgesics by chitosan
Development of Macrocyclic Neurotensin Receptor Type 2 (NTS2) Opioid‐Free Analgesics
Non-opioid (OTC) analgesics : risks/benefits in perspective
Nociceptin/orphanin FQ opioid peptide receptor-related ligands as potential analgesics in the endometriosis-associated pain
Oxycodone versus other opioid analgesics after laparoscopic surgery: a meta-analysis
Endomorphins: Promising Endogenous Opioid Peptides for the Development of Novel Analgesics
Differential interaction patterns of opioid analgesics with µ opioid receptors correlate with ligand-specific voltage sensitivity
Attenuated G protein signaling and minimal receptor phosphorylation as a biochemical signature of low side-effect opioid analgesics
Label-free integrative pharmacology on-target of opioid ligands at the opioid receptor family
Erratum to: Pain Management in Patients with Cancer: Focus on Opioid Analgesics
Enhancement of the intestinal epithelial permeability of peripherally acting opioid analgesics by chitosan
Correction to: Oxycodone versus other opioid analgesics after laparoscopic surgery: a meta-analysis